Navigation Links
Versus Technology Announces Fourth Quarter Results
Date:12/28/2007

TRAVERSE CITY, Mich., Dec. 28 /PRNewswire-FirstCall/ -- Versus Technology, Inc. ("Versus" or the "Company") announced revenues of $2,012,000 for the fiscal quarter ended October 31, 2007, compared to revenues of $2,177,000 for the same period in 2006. Revenues for the year ended October 31, 2007, were $5,566,000 compared to revenues of $5,812,000 for 2006. Versus' quarterly revenues can vary significantly depending on the timing and delivery of major customer projects. Accordingly, revenues reported in any one quarter are not necessarily indicative of what full year results will be.

Gross profits as a percentage of revenues increased to 71% for the quarter from 66% for the same period in 2006. For the year, gross profits increased to 67% compared to 64% in 2006.

The Company reported net income of $335,000 for the quarter compared to net income of $540,000 for the same period in 2006. Net losses for the years ended October 31, 2007 and 2006, were $208,000 and $1,692,000, respectively. The decrease in the reported net loss for the year was primarily attributable to the absence in 2007 of interest expense and accretion of debt discount that resulted from the 2006 redemption and conversion to common stock of the Company's Series B Debentures.

Versus generated positive cash flow from operations of $489,000 for the year ended October 31, 2007, compared to a use of cash from operations of $585,000 for the year ended October 31, 2006.

For additional information, please refer to the attached unaudited consolidated financial statements.

Versus Technology, Inc. (Pink Sheets: VSTI) (http://www.versustech.com) (Versus) is the leader in the development and sale of context-aware systems used for the management of patient flow and medical assets and to improve caregiver/patient communications in medical and long-term care facilities. Versus also supplies Active RFID/IR tags and readers t
'/>"/>

SOURCE Versus Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Quantum light beams good for fast technology
2. New Smart Technology Makes Patient Data Collection Easier, More Efficient
3. Align Technology Executive to Present at Upcoming Financial Conferences
4. Pioneer Surgical Technology Hires Vice President of New Business Development
5. Purdue researchers develop technology to detect cancer by scanning surface veins
6. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
7. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
9. Stevens Health, Technology and Society roundtable: Sept. 19
10. Microbiotic technology developed for microinjection of zebrafish embryos
11. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ss., Nov. 27 GSI Group I...r of precision technology products and semiconduct... of the Company,s shareholders has been scheduled ... of the meeting will be announced in due course. ...quisition notice from Stephen Bershad, a holder of...
(Date:11/27/2009)... 27 Considered a highly... years ago, solid organ transplantation is now a l...aordinary men and women who gathered at the Winspe...together from medical centers around the world to ...Transplant Institute (BRTI), one of the pioneers o...
(Date:11/27/2009)...R-SEINE, France, Nov. 27 Team Garm...ling team dedicated to ethical sporting and develo...ounced today that it will become Team Garmin-Trans... a new sponsor of the team. Transitions Optical is...ear, offering the most advanced photochromic techn...
(Date:11/27/2009)... low-emission vehicles may reduce future disease b...27 (HealthDay News) -- Encouraging city dwellers t...er much greater public health benefits than increa...s have found. , The study compared the projecte... transport scenarios for London, England, and Delh...
(Date:11/27/2009)... Voyant Health™ announced today that Spectr...s TraumaCad Enterprise orthopedic templating solut... (PRWEB) November 27, 2009...trum Health (Grand Rapids, Michigan) has licensed ...ution and its TraumaCad Extend workflow solution, ...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...y reserved for patients with Acute Myelogenous Le... transplantation graft failure or engraftme...id formulation; aims to restore US supplies o...on with the United States Food,and Drug Administra...
... faced with even a modest health insurance co-paym...eive these potentially life-saving breast cancer s...rsity and Harvard Medical School researchers. , I...s were 8 percent lower among women with a co-payme...
...,participating vendors raised $137,500 during its ...search and awareness at the Barbara Ann Karmanos,C...cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELOGO ...ant cause," said Rick Going, president of The Krog...
...Benefit the National Breast ... response to underbanked,customers, demonstrated d...,Corp., one of the premier providers of prepaid so...cess(R) Visa(R),Prepaid Card to benefit the Nation...
...armaceutical Research & Development, L.L.C. announ...NDA) to the U.S. Food and Drug,Administration (FDA...IR),tablets, an investigational oral analgesic for...ear as a result of injuries or,surgeries, and a re...
...ategies for Aging Baby,Boomers, ALEXANDRIA, Va., ...tion in Florida, the nation,s leading professional...e presidential candidates,of both parties to addre...their families deserve to,know what the next presi...
Other Medicine News:Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 3Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 4Health News:Health insurance co-payments deter mammography use 2Health News:Health insurance co-payments deter mammography use 3Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 2Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 3Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 2Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 3Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 4Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Assisted Living Federation Challenges Presidential Candidates 2
(Date:11/24/2009)... 24 /PRNewswire-Asia/ -- Chindex International, In...dent American provider of Western,healthcare produ..., today,announced that the Company will attend the... Conference, to be held December 1 - 2, 2009, at t... currently scheduled to present at 11:30 am ET on ...
(Date:11/24/2009)...ewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: EL...or aortic disorders, announced today that it has f...ngs in, the patent infringement lawsuit brought ag... was filed in the United States District Court in ...ed that the stay remain in effect while the United...
(Date:11/24/2009)...Newswire-FirstCall/ -- Vermillion, Inc. (VRML) (Pi...Plan of Reorganization and Disclosure Statement to...kruptcy Court for the District of Delaware. A hear...nt is presently scheduled for December 8, 2009, wi...eduled for January 7, 2010. ,, The Plan calls ...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo 28R 29 Complete Response Letter 6484 1Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo 28R 29 Complete Response Letter 6484 2News brief 3A Arsenic biomethylation required for oxidative DNA damage 61985 1Children who lack continuity with a regular health care provider miss needed services 61983 1Children who lack continuity with a regular health care provider miss needed services 61983 2Children who lack continuity with a regular health care provider miss needed services 61983 3
....C.--(BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,S...ed today,statistically significant results with BE...gh pain in its pivotal Phase III efficacy,clinical...chievement of the primary efficacy endpoint of the...), compared to placebo., The results demonstrated ...
... 25, 2007 /PRNewswire-USNewswire/ -- At least,one-...r first,appear in childhood or adolescence. Howeve... bipolar symptoms from those of other,disorders, n...th,Letter. , Children, especially young children, ...od episodes of mania and depression.,Also, many sy...
Other Medicine Technology:BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
Blue Line® Uncuffed Cut-to-Length Oral Endotracheal Tubes (Siliconized) Magill
Blue Line® Cuffed Oral/Nasal Endotracheal Tubes (Ivory) Magill
Uncuffed Oral Preformed
Uncuffed Nasoral Magill
Medicine Products: